Related references
Note: Only part of the references are listed.Emergence of Behcet's disease post-SARS-CoV2-vaccination: two clinical cases in Japan
H. Hashizume et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
Janus Kinase Inhibitors: Next-Generation Treatment for Uveitis
Yosuf El-Shabrawi et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2022)
Development and implementation of the AIDA International Registry for patients with Behcet's disease
Antonio Vitale et al.
INTERNAL AND EMERGENCY MEDICINE (2022)
COVID-19 in patients with Behcet's disease: Outcomes and rate of Behcet's exacerbations in a retrospective cohort
Bunyamin Polat et al.
MODERN RHEUMATOLOGY (2022)
Patterns of Uveitis in Egypt
Ahmed Abdelwareth Mohammed et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2021)
An Algorithm for the Diagnosis of Behcet Disease Uveitis in Adults
Ilknur Tugal-Tutkun et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2021)
Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study
Waleed A. Hassan et al.
CLINICAL RHEUMATOLOGY (2021)
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behcet's Syndrome
Jurgen Sota et al.
OPHTHALMOLOGY AND THERAPY (2021)
MONTHLY INTRAVITREAL INFLIXIMAB IN BEHcET'S DISEASE ACTIVE POSTERIOR UVEITIS A Long-Term Safety Study
Mohammad Refaat et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2021)
JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
Rita A. Moura et al.
FRONTIERS IN MEDICINE (2021)
Pediatric Behcet's Disease
Mehmet Yildiz et al.
FRONTIERS IN MEDICINE (2021)
Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review
Ji Wen et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Clinical profile and evolution of patients with juvenile-onset Behcet's syndrome over a 25-year period: insights from the AIDA network
Jurgen Sota et al.
INTERNAL AND EMERGENCY MEDICINE (2021)
Uveitis and Other Ocular Complications Following COVID-19 Vaccination
Elena Bolletta et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Post-remission retinal microvascular and choroidal thickness changes in eyes with Behcet's disease posterior uveitis: an OCTA longitudinal study
Amr Mohamed Abdelaziz Wassef et al.
INTERNATIONAL OPHTHALMOLOGY (2021)
Classification Criteria for Behcet Disease Uveitis
Douglas A. Jabs et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Diagnosis of Behcet's disease: clinical characteristics, diagnostic criteria, and differential diagnoses
Mina Kiafar et al.
BMC RHEUMATOLOGY (2021)
Off-label use of anti-IL-1 drugs in rheumatic diseases
Silvia Stefania et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2021)
Treatment considerations for Behcet disease in the era of COVID-19: A narrative review
Omer Faruk Elmas et al.
DERMATOLOGIC THERAPY (2021)
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behcet's Disease
Claudia Fabiani et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
Optical Coherence Tomography Angiography Findings in Active and Inactive Ocular Behcet Disease
Massimo Accorinti et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
Behcet's Disease, and the Role of TNF-α and TNF-α Blockers
Tim van der Houwen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
High-resolution wide-field OCT angiography with a self-navigation method to correct microsaccades and blinks
Xiang Wei et al.
BIOMEDICAL OPTICS EXPRESS (2020)
Behcet's Disease in Children: Diagnostic and Management Challenges
Giorgio Costagliola et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Modulation of gut microbiota through nutritional interventions in Behcet's syndrome patients (the MAMBA study): study protocol for a randomized controlled trial
Giuditta Pagliai et al.
TRIALS (2020)
Pediatric Behcet's disease - clinical aspects and current concepts
Mehmet Yildiz et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2020)
Fundus fluorescein angiography and optical coherence tomography findings in ocular and non-ocular Behcet's disease
Sara Mamdouh et al.
EGYPTIAN RHEUMATOLOGIST (2020)
Behcet's Uveitis: Current Diagnostic and Therapeutic Approach
Pinar Cakar Ozdal
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY (2020)
Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behcet's Uveitis: A Small Case Series
Hande Celiker et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behcet's Disease
Claudia Fabiani et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Efficacy of Dexamethasone Implants in Uveitic Macular Edema in Cases with Behcet Disease
Ozgur Yalcinbayir et al.
OPHTHALMOLOGICA (2019)
309. Biosimilar infliximab for behçet’s syndrome: a case series
Elif Dincses et al.
RHEUMATOLOGY (2019)
Clinical and Genetic Aspects of Behcet's Disease in Japan
Yohei Kirino et al.
INTERNAL MEDICINE (2019)
Early administration of adalimumab for paediatric uveitis due to Behcet's disease
Tomona Hiyama et al.
PEDIATRIC RHEUMATOLOGY (2019)
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behcet's Disease: National Multicenter Study of 177 Cases
Belen Atienza-Mateo et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study
Jarmila Heissigerova et al.
OPHTHALMOLOGY (2019)
Diagnostic/classification criteria in pediatric Behcet's disease
Ezgi Deniz Batu
RHEUMATOLOGY INTERNATIONAL (2019)
Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behcet's disease associated uveitis: a systematic review
Ana Urruticoechea-Arana et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy
Hilal Eser Ozturk et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2018)
Exploring the variability in Behcet's disease prevalence: a meta-analytical approach
Carla Maldini et al.
RHEUMATOLOGY (2018)
Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review
Ines Leal et al.
ACTA OPHTHALMOLOGICA (2018)
2018 update of the EULAR recommendations for the management of Behcet's syndrome
Gulen Hatemi et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis
Kathryn L. Pepple et al.
OPHTHALMOLOGY (2018)
Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behcet's disease: multicentre retrospective study
Belen Atienza-Mateo et al.
RHEUMATOLOGY (2018)
Relationship between age at onset and clinical characteristics of Behcet's disease
Mohammed El Amine Ghembaza et al.
ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA (2018)
Cumulative retention rate of adalimumab in patients with Behcet's disease-related uveitis: a four-year follow-up study
Claudia Fabiani et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2018)
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh‡et's disease-related uveitis: a multicenter retrospective observational study
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2017)
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2017)
Efficacy and safety of adalimumab in Beh‡et's disease-related uveitis: a multicenter retrospective observational study
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2017)
Review for Diagnostics of the Year: Multimodal Imaging in Behcet Uveitis
Ilknur Tugal-Tutkun et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2017)
Long-term Efficacy of Interferon in Severe Uveitis Associated with Behcet Disease
Eleonore Diwo et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2017)
Interferon Alpha-2a Therapy in Patients with Refractory Behcet Uveitis
Murat Hasanreisoglu et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2017)
Behcet Uveitis
Emmett T. Cunningham et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2017)
An update on the use of biologic therapies in the management of uveitis in Behcet's disease: a comprehensive review
Thomas W. McNally et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Assessment of Vascular Change Using Swept-Source Optical Coherence Tomography Angiography: A New Theory Explains Central Visual Loss in Behcet's Disease
Thanapong Somkijrungroj et al.
JOURNAL OF OPHTHALMOLOGY (2017)
Vitreomacular Interface Disorders in Behcet's Uveitis
Hilal Eser Ozturk et al.
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY (2017)
Rapid loss of efficacy of biosimilar infliximab in three patients with Behcet's disease after switching from infliximab originator
Fabrizio Cantini et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2017)
Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis
Yasir Jamal Sepah et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Successful treatment of Behcet's uveitis with Tocilizumab
F. Alokaily et al.
SAUDI JOURNAL OF OPHTHALMOLOGY (2017)
Knitting the Threads of Silk through Time: Behcet's Disease-Past, Present, and Future
Fahd Adeeb et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2017)
Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: PEDBD
Isabelle Kone-Paut et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Potential of Pegylated Interferon Alpha-2a in Behcet Uveitis: A Report of Five Cases
Philip Bielefeld et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2016)
Distinctions between diagnostic and classification criteria: comment on the article by Aggarwal et al
William J. Taylor et al.
ARTHRITIS CARE & RESEARCH (2016)
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
Quan Dong Nguyen et al.
LANCET (2016)
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease
Giacomo Emmi et al.
MEDICINE (2016)
Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Behcet's disease in children, an overview
Isabelle Kone-Paut
PEDIATRIC RHEUMATOLOGY (2016)
INTRAVITREAL INFLIXIMAB IN REFRACTORY UVEITIS IN BEHCET'S DISEASE A Safety and Efficacy Clinical Study
Mostafa M. E. Hamza et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review
Alban Deroux et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis A Multicenter Study From the French Uveitis Network
Helene Vallet et al.
ARTHRITIS & RHEUMATOLOGY (2016)
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH BEHÇET UVEITIS
Moncef Khairallah et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Intravitreal Adalimumab in Active Noninfectious Uveitis: A Pilot Study
Rola N. Hamam et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2016)
Continuous evolution of clinical phenotype in 578 Japanese patients with Behcet's disease: a retrospective observational study
Yohei Kirino et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Nonglaucomatous Localized Retinal Nerve Fiber Layer Defects in Behcet Uveitis
Merih Oray et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Intravitreal Dexamethasone Implant for Treatment of Refractory Behcet Posterior Uveitis: One-year Follow-up Results
Erol Coskun et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2015)
Anti-tumor necrosis factor-a therapy in uveitis
Miguel Cordero-Coma et al.
SURVEY OF OPHTHALMOLOGY (2015)
Automated Analysis of Vitreous Inflammation Using Spectral-Domain Optical Coherence Tomography
Pearse A. Keane et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2015)
Inner and outer segment junction (IS/OS line) integrity in ocular Behcet's disease
Harun Yuksel et al.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2014)
Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behcet's disease
Sho Ishikawa et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Long-term efficacy of infliximab on background vascular leakage in patients with Behcet's disease
H. Keino et al.
EYE (2014)
The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
F. Davatchi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
Grace Levy-Clarke et al.
OPHTHALMOLOGY (2014)
Objective Measurement of Vitreous Inflammation Using Optical Coherence Tomography
Pearse A. Keane et al.
OPHTHALMOLOGY (2014)
Evaluation of the Long-Term Efficacy and Safety of Infliximab Treatment for Uveitis in Behcet's Disease
Masaru Takeuchi et al.
OPHTHALMOLOGY (2014)
USE OF ULTRA-WIDE-FIELD RETINAL IMAGING IN THE MANAGEMENT OF ACTIVE BEHCET RETINAL VASCULITIS
Marina Mesquida et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
Light on the Horizont: biologicals in Behcet uveitis
Dicle Hazirolan et al.
ACTA OPHTHALMOLOGICA (2013)
Behcet Disease-associated Uveitis Successfully Treated with Golimumab
Marina Mesquida et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2013)
Differential Diagnosis of Behcet Uveitis
Ilknur Tugal-Tutkun et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2013)
Choroidal Thickness in Behcet's Uveitis: An Enhanced Depth Imaging-Optical Coherence Tomography and Its Association With Angiographic Changes
Min Kim et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Long-Term Effects of Intravitreal Infliximab for Treatment of Sight-Threatening Chronic Noninfectious Uveitis
Mohsen Farvardin et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Long-term Efficacy and Safety of Low-Dose and Dose-Escalating Interferon Alfa-2a Therapy in Refractory Behcet Uveitis
Sumru Onal et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Ocular Behcet disease: current therapeutic approaches
Cem Evereklioglu
CURRENT OPINION IN OPHTHALMOLOGY (2011)
Behcet Disease Evolution of Clinical Manifestations
Haruko Ideguchi et al.
MEDICINE (2011)
Behcet Disease in Children
Leyla Atmaca et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2011)
A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behcet's disease: a comparative 4-week study
Nikos Markomichelakis et al.
RHEUMATOLOGY (2011)
The Use of Biologic Agents in the Treatment of Ocular Manifestations of Behcet's Disease
Nicole R. Benitah et al.
SEMINARS IN OPHTHALMOLOGY (2011)
Classification and regression trees
Wei-Yin Loh
WILEY INTERDISCIPLINARY REVIEWS-DATA MINING AND KNOWLEDGE DISCOVERY (2011)
Three-Dimensional Visualization of Ocular Vascular Pathology by Optical Coherence Angiography In Vivo
Masahiro Miura et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behcet disease
Yukiko Yamada et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Intravitreal Adalimumab for Refractory Uveitis-Related Macular Edema
Sofia Androudi et al.
OPHTHALMOLOGY (2010)
Azathioprine in Severe Uveitis of Behcet's Disease
D. Saadoun et al.
ARTHRITIS CARE & RESEARCH (2010)
Ocular findings in childhood-onset Behcet disease
Mehmet Citirik et al.
JOURNAL OF AAPOS (2009)
Infliximab Effects Compared to Conventional Therapy in the Management of Retinal Vasculitis in Behcet Disease
Khalid F. Tabbara et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
EULAR recommendations for the management of Behcet disease
G. Hatemi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Demographic and clinical properties of juvenile-onset Behcet's disease: A controlled multicenter study
Yelda Karincaoglu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Safety and efficacy of infliximab therapy in active Behcet's uveitis: an open-label trial
H. Al-Rayes et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Neovascularization of the optic disc in Behcet's disease
Ilknur Tugal-Tutkun et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2006)
Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease
S Gedik et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2005)
Comparison of patients with Behcet's disease in the 1980s and 1990s
A Yoshida et al.
OPHTHALMOLOGY (2004)
Uveitis in Behcet disease: An analysis of 880 patients.
I Tugal-Tutkun et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Childhood-onset uveitis in Behcet disease: A descriptive study of 36 cases
I Tugal-Tutkun et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Indocyanine green angiography in Behcet's uveitis
A Klaeger et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2000)
Share Paper
